Recently, Gambaryan et al. [27] reported that the effect of CXCR4 antagonist on hypoxia-induced pulmonary hypertension and vascular remodeling in mice was associated with a significantly decreased number of perivascular c-kit+ hematopoietic progenitor cells. Here, CXCR4 is linked to pulmonary arterial hypertension.